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ABSTRACT
Background and study aims Nomenclature and descrip-
tions of small bowel (SB) vascular lesions in capsule endos-
copy (CE) are scarce in the medical literature. They are
mostly based on the reader's opinion and thus differ be-
tween experts, with a potential negative impact on clinical
care, teaching and research regarding SBCE. Our aim was to
better define a nomenclature and to give a description of
the most frequent vascular lesions in SBCE.
Methods A panel of 18 European expert SBCE readers was
formed during the UEGW 2016 meeting. Three experts con-
structed an Internet-based four-round Delphi consensus,
but did not participate in the voting process. They built
questionnaires that included various still frames of vascular
lesions obtained with a third-generation SBCE system. The
15 remaining participants were asked to rate different pro-
posals and description of the most common SB vascular le-
sions. A 6-point rating scale (varying from ‘strongly dis-
agree’ to ‘strongly agree’) was used successive rounds. The
consensus was reached when at least 80% voting members
scored the statement within the ‘agree’ or ‘strongly agree’.
Results Consensual terms and descriptions were reached
for angiectasia/angiodysplasia, erythematous patch, red
spot/dot, and phlebectasia. A consensual description was
reached for more subtle vascular lesions tentatively named
“diminutive angiectasia” but no consensus was reached for
this term.
Conclusion An international group has reached a consen-
sus on the nomenclature and descriptions of the most fre-
quent and relevant SB vascular lesions in CE. These terms
and descriptions are useful in daily practice, for teaching
and for medical research purposes.* Meeting presentations: 25th United European Gastroenterology
Week 2017
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Introduction
Capsule endoscopy (CE) is a minimally invasive technique that
allows complete visualization of the small bowel (SB) [1]. Dur-
ing its development in the 1990s, CE was immediately per-
ceived as a disruptive technology. Since its clinical inception in
2000, CE has rapidly become the first-line diagnostic tool to ex-
plore the SB, with a diagnostic yield of approximately 60% in
the setting of obscure gastrointestinal bleeding (OGIB), and
50% in suspected Crohn’s disease [2].
Because CE offers enhanced imaging of the SB mucosa, an
important effort has been made during the first few years of its
clinical use to design a structured lexicon for use in training, clin-
ical practice, and for research purposes [3–5]. The CE Struc-
tured Terminology (CEST) emerged through this work, but it
did not provide definitions nor full descriptions of themost com-
mon SB lesions. As a matter of fact, no clear definitions/descrip-
tions of vascular lesions have been widely accepted yet. A typical
example is “angiodysplasia” (AGD) that remains the most com-
mon vascular and obvious lesion found in SBCE in the setting of
OGIB [6]; however, there are controversies regarding the name,
description, and interobserver agreement of this diagnosis.
Some experts argue that the suffix “dysplasia” is inappropriate
from a pathological point of view, and that the term “ectasia”
should be preferred [7]. Nevertheless, in clinical practice, more
than half of reports use other terms, such as, “angioma,” “ecta-
sia,” “arteriovenous malformation,” “vascular ectasia,” or “vas-
cular malformation” [4].
In the medical literature, semantic descriptions of AGD are
scarce [6, 8], and are even more rare for more subtle vascular
lesions. In addition, in most studies aiming to evaluate interob-
server in describing CE findings, the “gold standard” for diag-
nosis is based on the experience of expert investigators, with-
out any description or definition of vascular lesions [9, 10].
Overall, names, descriptions, and diagnosis of vascular SB
lesions remain subjective. Still, when a putative diagnosis of SB
vascular lesion is made with CE, ablation therapy is first-line
treatment in most cases, pharmacological treatments are dis-
cussed, but endoscopic sampling or surgery followed by patho-
logical examination are rarely performed to confirm the diag-
nosis [6]. Overall, interobserver agreement for all lesions seen
in CE is moderate (kappa coefficient = 0.6) in the medical litera-
ture [10], and seems even lower for more subtle lesions.
Universal nomenclature and descriptions of SB vascular are
needed for CE reporting [11], medical education, and research.
The aim of this study was to achieve consensus on the nomen-
clature and descriptions of SB vascular lesions seen in CE.
Materials and methods
Design
The consensus process used a Delphi method, an established
method for obtaining answers to questions that cause uncer-
tainty even between experts [12, 13]. The study design was
based on alternative feedback rounds of a core group (CG) and
an expert group (EG) until consensus was achieved (▶Fig. 1).
Several Internet-based illustrated questionnaires were thus
from the CG to the EG for rating and comments. All question-
naires were structured in a similar way, with proposals for a no-
menclature and a semantic description, and calling for free
comments. Nomenclature and descriptions were revised by
the CG following each feedback round based on rating and of
the EG.
Working groups and feedback rounds
Working groups were formed aside the 24th United European
Gastroenterology Week (October 15–19, 2016, Vienna, Aus-
tria). The three investigators of the CG worked in Sorbonne Uni-
versity & APHP, Saint Antoine Hospital, Paris, France. The 15 in-
ternational investigators of the EG were based in England (n =1),
France (n =3), Israel (n = 2), Italy (n =3), Scotland (n=3), Spain
(n =1) and Sweden (n =2). Mean age of the EG was 47 years.
Mean CE reading experience of the EG was 13 years, with a
mean number of 100 CEs read annually.
Delphi consensus group establishment
core group (n = 3) experts group (n = 15)
Selection of the most common vascular lesions images 
seen in SB-CE* from the CAD-CAP** database 
Selection of 4 typical frames for each type of lesion
First set of proposals for nomenclature and descriptions 
of SB vascular lesions    
core group (n = 3)
Conference call/focus on more subtle vascular lesions
Consensual nomenclature and descriptions 
of most common SB vascular lesions seen in CE
Round 1 expert group 
(n = 15)
Post round 1 analysis 
(core group = 3) 
Round 2 expert group 
(n = 15)
Post round 2 analysis
(core group = 3)
Round 3 expert group 
(n = 15)
Post round 3 analysis
(core group = 3)
Round 4 expert group 
(n = 15)
Post round 4 analysis
(core group = 3)
▶ Fig. 1 Delphi Consensus Study flowchart. *SB-CE: Small bowel
capsule endoscopy, **CAD-CAP: Computer-assisted Diagnosis for
CAPsule endoscopy [14].
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Proposals and revisions of names and semantic
descriptions
The multicenter French database CAD-CAP (Computer-assisted
Diagnosis for Capsule endoscopy) was used. CAD-CAP is com-
posed of 20,000 normal CE still frames and 6013 still frames of
abnormal CE findings from third-generation SBCE system
videos (Pillcam SB3 system, Medtronic), including 2946 vascu-
lar lesions [14]. The CG selected an initial set of 100 still frames
of most common vascular lesion images seen in SBCE. Based on
this image dataset and on their knowledge, the members of the
CG categorized 5 different types of SB vascular lesions. For each
type of SB vascular lesion, the CG selected 4 typical frames
(with adequate mucosal visualization and brightness) and pro-
posed a putative name and a semantic description, to be sent to
the EG through an Internet-based questionnaire. At each
round, and for each type of lesion, members of the EG were
asked to rate proposals of the CG, on a numerical scale from 1
(strongly disagree) to 6 (strongly agree) (▶Table1), and to pro-
vide comments and suggestions for substantive revisions. After
each round, all suggestions from EG respondents were used by
the CG to improve names/descriptions.
Analysis
Consensus was reached when at least 80% of voting members
rated with a score of 5 (agree) or 6 (strongly agree) within four
rounds. Rounds were stopped for any lesion for which consen-
sual name and description were found. For any other lesion,
votes and comments were analyzed and discussed during
several face-to-face meetings by the three participants of the
CG in between the three first rounds. When consensual name
and description were not achieved after the third round, a tele-
conference was held between the CG and the EG. Then, the CG
made final revisions and provided a fourth questionnaire to the
EG, for a final vote. The process was stopped thereafter, wheth-
er a consensus was reach or not.
Results
The CG selected five types of common SB vascular lesions from
the CAD-CAP database. For each type of vascular lesions, a set
of 4 still frames (▶Fig. 2, ▶Fig. 3, ▶Fig. 4, ▶Fig. 5, ▶Fig. 6) was
sent, using Internet-based questionnaires, to the EG with tenta-
tive names and descriptions. Further feedback rounds between
the CG and the EG were scheduled until consensus was
achieved or until round 4 was reached. Consensual names and
definitions of “angiectasia/angiodysplasia” (▶Fig. 2), “erythe-
matous patch” (▶Fig. 3), “red spot/dot” (▶Fig. 4), and “phleb-
ectasia” (▶Fig. 5) were achieved within 3 rounds (▶Table 2).
However, a conference call and a final fourth round did not re-
sult in consensus on the name of more subtle vascular mucosal
abnormalities, tentatively named “diminutive angiectasia”
▶ Table 1 Six-point numerical scale to rate proposals during the
Delphi rounds.
1 Strongly disagree
2 Disagree
3 Moderately disagree
4 Moderately agree
5 Agree
6 Strongly agree
▶ Fig. 2 Four typical frames of “angiectasia/angiodysplasia,” as
presented to the expert group for voting.
▶ Fig. 3 Four typical frames of “erythematous patch,” as presented
to the expert group for voting.
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(▶Fig. 6), although a consensus was reached on their semantic
description. Numbers of voting experts for names and descrip-
tions are described more precisely for the last round in
▶Table3 and ▶Table4. Details on the votes for nomencla-
tures are given in ▶Supplementary Table 1.
Angiectasia/angiodysplasia
Regarding ▶Fig. 2, the terminology voted for after one round
with a 100.0% rate of agreement was an “angiodysplasia.” A
93.3% rate of agreement was found after Round 3 on the
following description: “a clearly demarcated, bright-red, flat
lesion, consisting of tortuous and clustered capillary dilatations
within the mucosal layer (surrounded by intestinal villi). Can be
small (few mm) to large (few cm).” However, there were con-
troversies regarding the name “angiodysplasia” versus “angiec-
tasia.” During post-Round 1 analysis, five experts mentioned
that they would have preferred the term “angiectasia.” Thus,
the core group decided to put the question to the vote during
the second round. After Round 2, no agreement was found as
60.0% of the experts preferred the term “angiectasia,” whereas
40.0% preferred the term “angiodysplasia.”
Erythematous patch
Regarding ▶Fig. 3, the terminology voted for after Round 2
with an 86.6% rate of agreement was an “erythematous patch.”
An 80.0% rate of agreement was found on the following de-
scription: “small (few mm) and flat reddish area, without any
vessel appearance within the mucosal layer (surrounded by
intestinal villi).”
Red spot/dot
Regarding▶Fig. 4, the terminology voted for after Round 1 with
a 93.3% rate of agreement was a “Red spot/dot.” An 80.0% rate
of agreement was found on the following description: “a minis-
cule (less than 1mm), punctuate, and flat lesion with a bright-
red area, without linear or vessel appearance within the mucosal
layer (surrounded by intestinal villi).” However, there were con-
troversies regarding the term “red dot” versus “red spot” and
▶ Fig. 6 Four typical frames of “diminutive angiectasia,” as pres-
ented to the expert group for voting.
▶ Fig. 5 Four typical frames of “phlebectasia,” as presented to the
expert group for voting.
▶ Fig. 4 Four typical frames of “red spot/dot,” as presented to the
expert group for voting.
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▶ Table 3 Experts’ rating regarding the nomenclature of the most frequent small bowel vascular lesions.
Nomenclature Numerical scale/Number of voting expert % of agreement or
strong agreement
Number of
rounds passed
1 2 3 4 5  6
Angiectasia/angiodysplasia 0 0 0 0 1 14 100% 1
Erythematous Patch 1 0 1 0 3 10 87% 2
Red spot/dot 1 0 0 1 4 9 93% 1
Phlebectasia 0 0 0 1 3 11 93% 1
“Diminutive angiectasia” 0 3 0 1 8 3 73%* 4
* Consensus was not reached
▶ Table 4 Experts’ rating regarding descriptions of the most frequent small bowel vascular lesions
Description Numerical scale/Number of voting expert % of agreement or
strong agreement
Number of
rounds passed
1 2 3 4 5 6
Angiectasia/angiodysplasia 0 0 0 1 5 9 93% 3
Erythematous Patch 2 0 0 1 9 3 80% 2
Red spot/dot 1 1 1 1 6 6 80% 1
Phlebectasia 0 0 1 1 4 9 87% 1
“Diminutive angiectasia”* 0 1 0 1 8 5 87% 4
* Consensus was not reached
▶ Table 2 International Delphi Consensus on the nomenclature and descriptions of the most frequent small bowel vascular lesions.
Nomenclature Semantic Description Nomenclature/Description % of
agreement or strong agreement
Angiectasia/angiodysplasia
A clearly demarcated, bright-red, flat lesion, consisting of tortuous
and clustered capillary dilatations, within the mucosal layer (surrounded
by intestinal villi). Can be small (few mm) to large (few cm).
100%/93%
Erythematous patch
A small (few mm) and flat reddish area, without any vessel appearance,
within the mucosal layer (surrounded by intestinal villi).
87%/80%
Red spot/dot
A miniscule (less than 1mm), punctuate, and flat lesion with a bright-red
area, without linear or vessel appearance, within the mucosal layer
(surrounded by intestinal villi).
93%/80%
Phlebectasia
A small (few mm), flat to slightly elevated, bluish venous dilatation
running below the mucosa (covered by intestinal villi).
93%/87%
Diminutive angiectasia*
A clearly demarcated, linear, bright-red lesion, consisting of tiny non-
clustered capillary dilatations, within the mucosal layer (surrounded by
intestinal villi).
73%/87%
* Consensus was not reached
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the CG decided to put this question to a vote. After Round 2, no
agreement was found, as 53.3% preferred the name “red spot,”
whereas 46.7% preferred the term “red dot.”
Phlebectasia
Regarding▶Fig. 5, the terminology voted for after Round 1 with
a 93.3% rate of agreement was a “phlebectasia.” An 86.6% rate
of agreement was found in Round 1 for the following descrip-
tion: “a small (few mm), flat to slightly-elevated, bluish venous
dilatation running below the mucosa (covered by intestinal
villi).”
‘Diminutive angiectasia’
Regarding ▶Fig. 6, the terminology voted for after Round 4
with only 73.3% rate of agreement was a “diminutive angiec-
tasia.” This lesion was the most difficult to name and to de-
scribe. Several proposals for terminology were discussed dur-
ing the three first rounds, among them “dilated capillaries,”
“small angiodysplasia,” “telangiectasia,” “engorged capillar-
ies,” “small arterial vascular malformation (AVM),” “atypical
AVM,” and “atypical AGD.” Experts failed to achieve a consen-
sus after Round 3. According to protocol, a conference call was
set up, for names and descriptions to be debated before a final
vote. At Round 4, there was an 86.6% rate of agreement on the
following description: “a clearly demarcated, linear, bright-red
lesion, consisting of tiny non-clustered capillary dilatations,
within the mucosal layer (surrounded by intestinal villi).”
Discussion
This study established nomenclature and descriptions for some
of the most common vascular lesions seen in SB-CE. Through a
Delphi consensus conducted with a significant number of CE ex-
pert readers, four names and their semantic descriptions were
validated with more than an 80% rate of agreement: “angiecta-
sia/angiodysplasia” (93.3%), “erythematous patch” (80.0%),
“red spot/dot” (80.0%), and “phlebectasia” (86.6%) (▶Table 2).
Since the early 2000s, CE offers a new insight into SB pathol-
ogy. Although an effort has been made initially to create a lexi-
con to describe SBCE findings [4], there has been no dictionary
(with an entry name and a corresponding description) of SB
vascular lesions since. This makes it difficult to attempt to
standardize SBCE reading, reports, and research. For example,
to date, most studies aiming to evaluate interobserver agree-
ment in the description of SBCE findings have used the expert
investigators’ opinion as gold standard for diagnosis [10], rath-
er than any validated name or description of SB vascular lesions.
Consensus methods are being used increasingly to solve
problems in medicine. Their main purpose is to define levels of
agreement on controversial subjects. As a mean of achieving
consensus on an issue, the Delphi methodology has become
widely used in healthcare research [15, 16]. The literature on
this technique is expanding, mainly addressing what it is and
how it should be used [13, 17]. Given the need for a SB vascular
lesions dictionary, we considered that Delphi methodology a
good approach for large-scale research. However, Delphi
methodology has some limitations. Therefore, we paid special
attention to clearly separate the CG from the EG, with different
settings and different tasks. The CG was a small group of three
physicians from the same center who had experience in SB-CE
reading, teaching, and research. Members of the CG were able
to attend consensus meetings and aimed to make proposals
and revisions based on the EG votes and comments but they
did not vote. The EG comprised 15 European opinion leaders in
SB-CE. They were chosen based on their long experience (mean
13 years) and on their high volume of SB-CE reading (mean 100
cases a year). This study has other strengths. All Internet-based
answers were anonymous, to allow the experts to express any
contradictory view or even to change their mind during the vot-
ing rounds. The participation rate for all questionnaires reached
100% in all rounds.
Some limitations should be mentioned as well. First, the CG
of three physicians from the same institution made the initial
image dataset and proposals for names and descriptions, possi-
bly misleading the EG from the very start. Other names, terms,
and definitions could have emerged from a larger or more
heterogeneous group. Second, questionnaires and votes were
Internet-based, except one conference call. It is likely that a
conference call or physical meeting would have created more
debate, controversy, and enrichment of vocabulary for names
and descriptions than comments on a website without any live
interaction. However, free comments were still possible
through the Internet-based questionnaire, and at the time of
the conference call after Round 3. Third, some rare, protruding
or syndrome-related vascular lesions were not addressed in this
study (hemangioma, varices, Kaposi sarcoma, blue rubber bleb
syndrome, for example). We believe that there was an urge to
build a consensus on the most frequent vascular lesions seen
in SB-CE. However, many other less frequent vascular lesions
will also need to be better defined. Fourth, some differences in
descriptions of vascular lesions are based on the lesion size.
Although a team has proposed measuring the size of SB polyps
using reference granules in patients with Peutz-Jeghers syn-
drome [18], there is currently no validated system for size
measurement in SBCE. Fifth, this consensus aimed to brush up
the nomenclature and semantic descriptions of SB vascular
lesions, not to provide their clinical relevance in terms of bleed-
ing. Our group is now strongly considering doing another
Delphi consensus on the significance of the SB vascular lesions
named and described herein.
Some issues have not been fully solved by this study.
Although their description was consensual, there were some
controversies regarding the choice for a name between “angio-
dysplasia” and “angiectasia.” The core group decided to put
that question to the vote during Round 2 but no agreement
was found as 60.0% of the experts preferred the term “angiec-
tasia,” whereas 40.0% preferred the term “angiodysplasia.”
Thus, in the experts’ view, there would be a slight preference
for the term “angiectasia” for daily practice. For some experts,
the term “angiodysplasia” is widely used in clinical practice and
in research, and refers adequately to the above-described vas-
cular lesion. However, some other experts argue that the suffix
“dysplasia” is inappropriate because the lesion is not an epithe-
lial anomaly of growth and differentiation, which for patholo-
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gists usually indicates a precancerous lesion. However, in
Ancient Greek, “dys” means difficult and “plasso” means
formed, and “angiodysplasia” would therefore etymologically
mean “vascular malformation,” with no reference to precancer-
ous change in cells and tissues [19]. Indeed, the term “dyspla-
sia” is used in other benign conditions, such as hip, kidney or
bone dysplasia. On the other hand, “ektasis” means “dilation”
[19], and seems very appropriate to describe mucosal capillary
dilations seen by pathologists in the rare cases in which such
lesions are sampled. Overall, some slight confusion may still
ensue with the different terms “angiectasia” (also sometimes
written “angioectasia”) and “angiodysplasia,” although they
relate to the very same type of lesion and may be considered
as synonyms. Indeed, in the study validating the Capsule Endos-
copy Standardized Terminology, the term “angiectasia” was
used as an “obvious synonym” for the term “angiodysplasia” in
435 out of 486 occurrences for the experts [4]. For even more
subtle lesions, such as so-called “diminutive angiectasia,” we
were not able find a consensus name (only a 73.3% agreement
was reached), although a consensus description was made.
Conclusion
In conclusion, the effort carried out by an international group
through this consensus statement on nomenclature and de-
scriptions of the most frequent SB vascular lesions represents
a step forward in standardization of SB-CE reading, teaching,
and medical research on this topic.
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▶ Supplementary Table 1 Proposed nomenclature/agreement for five different types of small bowel vascular lesions.
Vascular lesions
images
Round 1
Proposed term
% of agreement
Round 2
Proposed term
% of agreement
Round 3
Proposed term
% of agreement
Round 4
Proposed term
% of agreement
▶ Figure 2 Angiodysplasia
100.0
Angiodysplasia
40.0
vs.
Angiectasia
60.0
/ /
▶ Figure 3 Red spot
53.3
Erythematous patch
86.6
/ /
▶ Figure 4 Red dot
93.3
Red dot
46.7
vs.
Red spot
53.3
/ /
▶ Figure 5 Phlebectasia
93.3
/ / /
▶ Figure 6 Telangiectasia
66.7
Angiectasia
66.7
Small angiodysplasia
53.3
Atypical angiodysplasia
0.0
Engorged capillaries
20.0
Small AVM*
20.0
Atypical AVM
13.3
Unclassified small-bowel
subtle vascular lesions
20.0
Undetermined small-bowel
subtle vascular lesions
33.3
Diminutive angiectasia
73.3
Dilated capillaries
26.7
* AVM=Arterial vascular malformation
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